Skip to content

PHARBEL

Active Public limited companyfounded 1992active for 33 yearsRogierlaan 116, 1030 SchaerbeekKBO/BCE: BE 0449.266.386

Lifetime

20 annual accounts with figures on one time axis, 33 filings since 1993
peak of €1.4m in 2024
€1.0m▼ 25.5%
lowest -€13,372 in 2009
€139,948▼ 66.1%
peak of €1.3m in 2025
€1.3m▲ 3.9%
€1.5m▼ 22.1%
peak of 8.8 FTE in 2023
6.9 FTE▼ 16.9%
Board2 names since 2003
2 directors and 1 other
Documentsfilings and deeds
26-06-202635 days before the deadline
2025abbreviated format
Gross margin from €1.4m to €1.0mResult from €413,138 to €139,948Staff from 8.3 FTE to 6.9 FTEDividend €90,000Debts from €1.9m to €1.5mCash from €381,572 to €202,962

Key points

from the 2025 annual accounts

Equity

€1.3m ▲ 3.9%
1.32024+0.1Profit-0.09Dividend1.32025

PHARBEL paid out €90,000 in dividends. That is 64% of the 2025 profit.

Result

€139,948 ▼ 66.1%
€413,0002024€140,0002025

The result fell in 2025: the 2024 profit included a one-off income of €295,647.

Turnover

≈ €4.3m estimated

The accounts state no turnover.

Investments

€48,966 0.3 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Staff

7 employees on 31-12-2025
212021202022112023132024232025

In 2025, 2 employees joined and 3 left.

Filings

33 annual accounts since 1993
AprilJune31 JulyOctober200020102020

Three of the last ten came late. The 2018 accounts came in latest, 26 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,048 companies had the same profile as PHARBEL has now. Each dot stands for 43 companies, two years later.

94.3%
were still trading
5.0%
stopped another way
0.6%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,048 companies, not a prediction for PHARBEL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0449266386
Registered office moved within Schaerbeek The registered office moved from Avenue Rogier 104, 1030 Schaerbeek to Avenue Rogier 116 à 1030 Schaerbeek · Board meeting of 19-09-2022 · Gazette deed
1 director appointed, 1 resignation changes role from director to mandate holder · resigns · appointed as sole director · General meeting of 19-08-2021 · Gazette deed
resigns as director appointed as director · General meeting of 11-06-2020 · Gazette deed
All 52 events

Comparable companies

same main activity, similar in size and age
Company
PHARBEL Schaerbeek €2.8m €1.0m 46.8% 6.9
ABISCO Kontich €2.7m €1.0m 81.4% 6.4
PHARMAYOU WANZE Wanze €3.1m €1.0m 46.4% 7
Immed Benelux Uccle €2.7m €1.1m 50.9% 6.6
DHCare Belgium Zedelgem €2.8m €1.2m 47.7% 9.4
YVSOLAB Turnhout €2.0m €0.8m 33.5% 7
BELDIMED Dison €2.2m €0.8m 31.5% 8.7

These companies have the same main activity as PHARBEL: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €2m and €3.1m, founded between 1987 and 1999.

Official details

Source: KBO
Status
Active since 15-12-1992Normal situation
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 2 others
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.178.231.5051030 Schaerbeek, since 01-04-2009
Financial year end
31 December
Peppol
Reachable since 24-11-2025
Company details

Annual accounts 2025

€2.8m▼ 11.8%
Employeeson 31-12-2025
7▼ 12.5%
Filing
Filed on 26-06-2026, 35 days before the end of the filing period
Financials

Insights on PHARBEL

PHARBEL files the abbreviated format. That format states no turnover. The gross margin rose from €73,352 in 2006 to €1.0m in 2025.

The balance sheet grew most from 2020 to 2022 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARBEL

What is the company number of PHARBEL?
The company number of PHARBEL is 0449.266.386. The VAT number is the same number with BE in front: BE 0449.266.386.
Where is PHARBEL based?
The registered office is at Rogierlaan 116, 1030 Schaerbeek.Company details
What does PHARBEL do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of PHARBEL?
PHARBEL is a public limited company (NV).
When was PHARBEL founded?
PHARBEL was founded on 15-12-1992.
Is PHARBEL still active?
Yes, PHARBEL is an active enterprise in the KBO register.
How many employees does PHARBEL have?
PHARBEL had an average of 6.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARBEL fall under?
In its 2025 annual accounts, PHARBEL states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARBEL?
The turnover in financial year 2025 is about €4.3m. This figure is estimated from the gross margin of €1.0m and 97 comparable companies (NACE 46). It probably lies between €2.6m and €7.2m.
Is PHARBEL profitable?
In financial year 2025, PHARBEL made a profit of €139,948.
Where can I find the annual accounts of PHARBEL?
PHARBEL filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARBEL due?
PHARBEL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.